TMOD-42. PROSPECTIVE VALIDATION OF AN EX VIVO 3D ASSAY FOR PREDICTION OF TEMOZOLOMIDE RESPONSE IN GLIOBLASTOMA

Standard treatment for newly diagnosed glioblastoma (GBM) is surgical resection followed by radiation with concurrent temozolomide (TMZ). For those who do not respond there are few clinical options, survival is low, and there no biomarkers to direct the decision of second-line treatment. We have dev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Smith, Ashley, Holmes, Lillia, Shuford, Stephen, Kanos, Charles, Gardner, Stephen, Hodge, Philip, Lynn, Michael, Edenfield, Jeff, DesRochers, Teresa
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2019
Schlagworte:
Tumor Models
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6845946/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1141
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge